Illumina
Definition
The dominant NGS platform company, using sequencing by synthesis (SBS) with fluorescently labeled reversible terminators. Illumina platforms (MiSeq, NextSeq, NovaSeq) produce short reads (75-300 bp) with very low error rates (less than 0.1%), high throughput (up to 6 Tb per NovaSeq X run), and low per-base cost. Illumina sequencing is the gold standard for clinical genomics and large-scale genomic studies.
In Practice
Illumina is widely used in sequencing and related fields. Key applications include:
- Research and experimental design in molecular biology laboratories
- Clinical diagnostics and therapeutic development pipelines
- Automated validation within VigyanLLM's 24-step primer design and analysis framework
Frequently Asked Questions
What is Illumina?
Illumina's dominant NGS platform uses sequencing by synthesis with fluorescent reversible terminators, producing 75-300 bp reads with less than 0.1% error rate on platforms from MiSeq to NovaSeq. Explore the full definition and applications on this page.
How does Illumina relate to next-generation sequencing?
Illumina is closely connected to next-generation sequencing and other Sequencing concepts. Understanding these relationships is essential for comprehensive knowledge in molecular biology and bioinformatics.
How does VigyanLLM use Illumina in its pipeline?
VigyanLLM's 24-step validated pipeline incorporates Illumina as part of its rigorous quality control framework. The platform automates checks related to Illumina to ensure primer design accuracy, specificity, and reliability for research and clinical applications.
VigyanLLM Application
VigyanLLM's validated pipeline addresses next-generation sequencing and Illumina through automated computational checks. Explore how the platform handles Illumina across its 24-step framework: